Spironolactone
Product Images NDC 10544-523

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 10544-523). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label 30ct (Label Spironolactone Tabs 25mg Bpi(10544 523 30) Amneal(65162 511 11) Rev2)

Label 30ct (Label Spironolactone Tabs 25mg Bpi(10544 523 30) Amneal(65162 511 11) Rev2)
This is a description of Spironolactone Tablets, USP. The package contains 30 tablets of 25mg each, for prescription use only. The dosage should be as indicated in the package insert. The tablets should be stored in a controlled room temperature between 20°-25°C (68-17°F), in a light-resistant container, and out of the reach of children. The lot numbers and expiration dates are BPOD00000D, 00/00/0000, BPOOO0OSO0, 000000, BPOGOOOSDO, 00100000, BPOB0000D0, 00IGIO000, and BPOOO00D00, 001010000.*
FDA Label Image

Structure (Spironolactone Tablets Usp 1)

FDA Label Image

Structure (Spironolactone Tablets Usp 2)

Structure (Spironolactone Tablets Usp 2)
This text seems to be presenting statistical information related to two groups of individuals, one taking a medication called Spironolactone and the other group referred to as Piaceto. It mentions the number of individuals in each group (822 and 841) and a p-value of less than 0.001. The numbers "12 18 2% 30 3 4 48" are not clearly related to the information presented and their meaning is not apparent.*
FDA Label Image

Graph3 (Spironolactone Tablets Usp 3)

Graph3 (Spironolactone Tablets Usp 3)
This appears to be a table showing the results of a study or experiment comparing the effectiveness of Spironolactone and Placebo for different subgroups. The title of the table is "Subgroup". However, without context, it is difficult to provide a more detailed description.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.